Peptides enhancing CEH activity or inhibiting ACAT activity, pharmaceutical compositions comprising these peptides and their use in the treatment of atherosclerosis

Details for Australian Patent Application No. 2004247286 (hide)

International Classifications

Event Publications

22 December 2005 PCT application entered the National Phase

PCT publication WO2004/111084 Priority application(s): WO2004/111084

29 November 2007 Amendment Made

The nature of the amendment is: Amend the invention title to read Peptides enhancing CEH activity or inhibiting ACAT activity, pharmaceutical compositions comprising these peptides and their use in the treatment of atherosclerosis

3 February 2011 Application Accepted

Published as AU-B-2004247286

2 June 2011 Standard Patent Sealed

14 June 2012 Assignment Registered

Queen's University At Kingston The patent has been assigned to The University of Chicago

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.